We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STNE icon
2576
StoneCo
STNE
$2.16B
-28,646
Closed -$995K
SY
2577
So-Young International
SY
$230M
-11,700
Closed -$50K
SYNA icon
2578
Synaptics
SYNA
$3.82B
-8,756
Closed -$1.57M
TBLA icon
2579
Taboola.com
TBLA
$1.01B
-12,866
Closed -$109K
TBPH icon
2580
Theravance Biopharma
TBPH
$883M
-14,791
Closed -$109K
TCBI icon
2581
Texas Capital Bancshares
TCBI
$4.27B
-20,981
Closed -$1.26M
TCBK icon
2582
TriCo Bancshares
TCBK
$1.76B
-21,652
Closed -$940K
TCX icon
2583
Tucows
TCX
$103M
-3,440
Closed -$272K
TECH icon
2584
Bio-Techne
TECH
$11.3B
-21,880
Closed -$2.65M
TER icon
2585
Teradyne
TER
$58.7B
-180,083
Closed -$19.7M
TFII icon
2586
TFI International
TFII
$11.6B
-2,232
Closed -$228K
TG icon
2587
Tredegar Corp
TG
$278M
-16,700
Closed -$203K
THRM icon
2588
Gentherm
THRM
$1.24B
-5,818
Closed -$471K
TIGR
2589
UP Fintech Holding
TIGR
$952M
-18,863
Closed -$200K
TISI icon
2590
Team
TISI
$104M
-1,188
Closed -$36K
TLRY icon
2591
Tilray
TLRY
$666M
-2,521
Closed -$285K
TM icon
2592
Toyota
TM
$234B
-3,800
Closed -$675K
TLYS icon
2593
Tilly's
TLYS
$120M
-17,859
Closed -$250K
TME icon
2594
Tencent Music
TME
$14.4B
-15,200
Closed -$110K
TOST icon
2595
Toast
TOST
$21.2B
-157,103
Closed -$7.85M
TR icon
2596
Tootsie Roll Industries
TR
$3.08B
-13,781
Closed -$362K
TRIP icon
2597
TripAdvisor
TRIP
$1.17B
-28,394
Closed -$961K
TRUP icon
2598
Trupanion
TRUP
$1.36B
-3,197
Closed -$248K
TSCO icon
2599
Tractor Supply
TSCO
$18.2B
-35,325
Closed -$1.43M
TT icon
2600
Trane Technologies
TT
$99.8B
-71,655
Closed -$12.4M

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.